Hamonic G, Pastural E, Arora S, Lew J, et al. Safety and immunogenicity of COVAC-2, a Sepivac SWE adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial. Vaccine 2025;64:127748.
PMID: 40957309